Since the breakthrough that led to the development of xMAP® Technology—the original idea that using different fluorophore colors could enable the detection of more than one analyte at a time—we have continued to build on what xMAP Technology can do, working with researchers from around the world to streamline immunoassays, expand discovery, and support innovation.
Need help using xMAP® Technology to couple beads or develop a new assay? Our team of expert scientists has you covered!
Not all users have the time or expertise to develop new assays, and custom immunoassay services are in huge demand. To meet that need, we’ve expanded our team and developed a service dedicated to developing custom assays—the LuminexPLORE Lab.
For the past 25 years, xMAP® Technology has been the gold standard in bead-based multiplexing. Building on this proven performance, xMAP INTELLIFLEX brings exciting new benefits, including low- and high-plex capabilities, quick time to reliable results, and dual reporter capability, which delivers data for two parameters per analyte simultaneously for up to 500 analytes per well.
While early measurements of COVID-19 patients’ antibodies against SARS-CoV-2 focused on the IgG isotype, IgA and IgM responses are also important for fully understanding the body’s immune response to COVID-19.
Whether you’re a new or experienced xMAP Technology user, our Technical Support Team can help you! They’ve compiled five tips based on questions that users frequently ask.
In a recent study, researchers used xMAP® Technology to design a multiplex assay from two separate immunogenicity assays to simultaneously identify and isotype ADAs in humans who received Humira®, a TNF inhibitor with a well-documented immunogenicity profile that is commonly used to treat rheumatoid arthritis and other inflammatory disorders.
xMAP® Technology offers significant advantages in recent comparison to electrochemiluminescence platform. It’s…
New white paper reviews a host of recent studies based on xMAP® Technology When Luminex scientists first creat…
UT Austin students share their experience working in our xMAP® Custom Assay Development lab this past summ…
Multiplex serology tests have yielded impressive results, showing promise for use in the COVID-19 pandemic. xM…